Concentration of sales in the blood collection tube preparation equipment business and reliance on market share
First written in FY2016. 7 of 8 entries say "Restated". Latest entry: FY2024.
No other company in this theme has enough history to compare yet.
- FY2024RestatedAnnual report
「The blood collection tube preparation equipment and systems business and related consumables account for approximately 70% of the company's total revenue.」
The company has reconfirmed the structural risk that approximately 70% of revenue remains concentrated in the blood collection tube preparation equipment and systems business and related consumables. - FY2023RestatedAnnual report
「The blood collection tube preparation equipment and systems business and related consumables account for approximately 70% of the company's total revenue.」
The company has reconfirmed the structural risk that approximately 70% of revenue remains concentrated in its core business and related consumables. - FY2022RestatedAnnual report
「The blood collection tube preparation equipment and systems business and related consumables account for approximately 70% of the company's total revenue.」
The company continues to reconfirm that revenue concentration in its core business and related consumables remains approximately 70%. - FY2021RestatedAnnual report
「The blood collection tube preparation equipment business and related consumables account for approximately 70% of the company's total revenue.」
The company continues to reconfirm that revenue concentration in the blood collection tube preparation equipment business and related consumables remains around 70%. - FY2019RestatedAnnual report
「The blood collection tube preparation equipment business and related consumables account for approximately 70% of the company's total revenue.」
The company continues to reconfirm that revenue concentration in the blood collection tube preparation equipment business and related consumables remains around 70%. - FY2018RestatedAnnual report
「The blood collection tube preparation equipment business and related consumables account for approximately 70% of the company's total revenue.」
The company continues to reconfirm that revenue concentration in the blood collection tube preparation equipment business and related consumables remains around 70%. - FY2017RestatedAnnual report
「The blood collection tube preparation equipment business and related consumables account for approximately 70% of the company's total revenue.」
The company has reconfirmed that revenue concentration in its core business and related consumables remains approximately 70%, indicating the need to reduce this dependence. - FY2016First statedAnnual report
「The blood collection tube preparation equipment business and related consumables account for approximately 70% of the company's total revenue. Given this high level of dependence, a contraction in market size due to external factors such as tighter healthcare finances, or a decline in profitability if the company fails to accurately capture market trends and needs for next-generation equipment, could have a material impact on its results.」
The company recognizes concentration risk, with its core business and related consumables accounting for approximately 70% of revenue.